AG真人官方

Uber Technologies, Inc. (UBER) has filed a Form 4 revealing that director Nikesh Arora was granted 55 restricted stock units (RSUs) on 10 July 2025 under the company鈥檚 RSU Conversion and Deferral Program for Directors. These RSUs were 100% vested at grant and carry a $0.00 exercise price; they will settle on a one-for-one basis in either cash or common stock when Arora鈥檚 board service ends, at Uber鈥檚 discretion. No open-market transactions, purchases, or sales occurred, and Arora鈥檚 direct beneficial ownership now stands at 55 derivative securities representing common shares. The award is part of routine director compensation and is immaterial to Uber鈥檚 share count or earnings, implying a neutral effect on near-term investor considerations.

180 Life Sciences Corp. (NASDAQ: ATNF/ATNFW) filed an 8-K on 11-12 July 2025 disclosing compensation-related actions approved by its Board of Directors.

• Accelerated vesting 鈥� executives: The Board accelerated in-full vesting of (i) 435,000 stock options (exercise price $0.9290; 10-year term) and (ii) 175,750 restricted shares previously granted on 17 June 2025 to CEO Blair Jordan and CAO Eric Van Lent.
• Accelerated vesting 鈥� non-executive directors: Vesting of 530,000 options (same $0.9290 exercise price) and 214,579 restricted shares granted on 17 June 2025 to three independent directors was likewise accelerated.
• Shareholder approval still required: Under Nasdaq rules and the company鈥檚 2025 Option Incentive Plan, none of the accelerated options may be exercised until shareholders approve the 2025 Plan. If approval is not obtained within one year of adoption, all options issued under the plan will be cancelled.
• Consulting agreement amendment: On 12 July 2025, the company, Eric Van Lent and EVL Consulting, LLC extended Mr. Van Lent鈥檚 Executive Consulting Agreement through 31 Dec 2025 and increased the early-termination fee from $10,000 to $25,000.
• No financial or operational metrics were reported.

The filing contains updated exhibits for the 2025 Option Incentive Plan, related award agreements and the amended consulting agreement.

UBS AG is offering $2.001 million of Trigger Autocallable Contingent Yield Notes that mature on 14 July 2027. The notes are linked to the least-performing of two underlying assets: (1) the common stock of NextEra Energy, Inc. (NEE) and (2) the S&P 500庐 Index (SPX).

Key economic terms

• Issue price: $1,000 per note; CUSIP 90309KDF8
• Contingent coupon rate: 8.85 % p.a. (monthly $7.375 if payable)
• Coupon barrier: 55 % of each initial level
    鈥� NEE $40.51
    鈥� SPX 3,444.79
• Automatic call: monthly observations beginning after 14 months; callable when each underlying 鈮� 100 % of its initial level
• Downside threshold (55 % of initial level): identical to coupon barrier
• Initial levels (strike date 9-Jul-2025): NEE $73.65; SPX 6,263.26
• Estimated initial value: $979.70 (reflects underwriting discount $4.00 and internal funding adjustments)

Payment mechanics

• Coupons: Paid only if both underlyings close 鈮� their respective coupon barriers on an observation date. If any underlying is below its barrier, the coupon for that month is forfeited.
• Automatic call: If both underlyings close 鈮� their call thresholds (100 % of initial level) on any observation date after month 14, investors receive principal plus the applicable coupon and the notes terminate early.
• Maturity: 鈥� If no call and both underlyings 鈮� downside thresholds, principal is repaid.
  鈥� If no call and any underlying < downside threshold, redemption amount = principal 脳 (1 + return of worst-performing asset). Investors may lose up to 100 % of principal.

Risk highlights

• Full downside exposure: If either underlying falls > 45 % from its initial level at final valuation, repayment is proportionally reduced.
• Credit risk: All payments depend on the senior unsecured credit of UBS AG; the notes are not FDIC-insured.
• Liquidity: The notes will not be listed; secondary market making is discretionary and may reflect significant bid-ask spreads.
• Valuation gap: Issue price exceeds estimated initial value by $20.30 per note due to fees and hedging costs.

Timeline

• Strike: 9-Jul-2025  |  Trade: 10-Jul-2025  |  Settle: 15-Jul-2025 (T+3)
• Monthly observation dates through 9-Jul-2027
• Maturity / final payment: 14-Jul-2027

Offering details

• Total proceeds to UBS: $1,992,996; underwriting discount: $8,004
• Dealer: UBS Securities LLC, with re-allowance to third-party dealers

Suitability: Product targets investors who (i) can tolerate loss of principal, (ii) seek high conditional income, (iii) are comfortable with performance of both NEE and the S&P 500, and (iv) understand that coupons are not guaranteed and that early redemption may occur.